PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Tattoo

Imaging considerations included in tattoo guidelines for at-risk cancer population

Cases of mistaken malignancy have become more common as the popularity of tattoos has grown in recent years.

April 13, 2023
PET/MRI of FAPI radiotracer uptake in Crohn's disease

New imaging technique could change how Crohn's disease is treated

The FAPI radiotracer experts used in this research can bind specifically to the connective tissue cells that cause intestinal wall fibrosis common to Crohn's disease.

April 5, 2023
Cardiologist heart

Advanced imaging does not always improve outcomes, data suggest

Although advanced imaging exams have proven benefits in defining disease severity, new data indicate that more sophisticated studies might not impact outcomes as much as previously thought. 

March 13, 2023

New practice guidelines for PET imaging of neuroendocrine tumors

Issued by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM), the new guidelines are intended to inform any practitioners involved in ordering, performing, reading and reporting SSTR PET imaging.

February 22, 2023

Amyloid plaque patterns on PET imaging predict Alzheimer's progression in asymptomatic patients

Experts involved in the new research suggest that identifying these spatiotemporal variations could play an important role in clinical research and precision medicine. 

February 8, 2023

E-cigarettes cause worse inflammation than tobacco cigarettes, new PET data shows

The use of e-cigarettes has increased significantly in recent years, mostly due to the fact that many consumers believe them to be a safer option than traditional cigarettes.

January 25, 2023
new radiotracer studies inflammation

New radiotracer could change how radiologists understand inflammation

Labeled as LW223, the fluorinated PET radiotracer is the first of its kind to be impervious to rs6971 polymorphism—a genetic mutation that inhibits the diagnostic view of inflammation imaging.

January 24, 2023

A 'clear lack of adherence' in imaging guidelines is impacting lung cancer survival rates

A study published in the January issue of the Journal of Nuclear Medicine reveals that nearly half of Medicare patients with NSCLC in the United States do not complete recommended FDG PET/CT scans prior to treatment.

January 19, 2023